StonvexLoading…
StonvexStonvexStonvexCore line items from TRIP's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.89B | $1.83B | $1.79B | $1.49B |
Operating Income | $80.00M | $92.00M | $126.00M | $101.00M |
Net Income | $40.00M | $5.00M | $10.00M | $20.00M |
EPS (Diluted) | $0.31 | $0.04 | $0.08 | $0.14 |
Total Assets | $2.63B | $2.56B | $2.54B | $2.57B |
Total Liabilities | $1.98B | $1.62B | $1.67B | $1.71B |
Cash & Equivalents | $1.03B | $1.06B | $1.07B | $1.02B |
Free Cash Flow OCF − CapEx | $163.00M | $70.00M | $172.00M | $344.00M |
Shares Outstanding | 114.47M | 127.39M | 124.88M | 128.05M |